karen

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of NovartisNovartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

Novartis appoints Karen Hale, Chief Legal and Compliance Officer, as Klaus Moosmayer, Chief Ethics, Risk & Compliance Officer, steps down from the Executive Committee of Novartis

After nearly seven years as a member of the Executive Committee of Novartis (ECN), Klaus Moosmayer will pursue his next…

1 month ago
Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent DirectorAscend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

Ascend Advanced Therapies Appoints John Chiminski as Chair and Karen Flynn as Independent Director

ROCKVILLE, Md., March 5, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene to GMP advanced therapy development partner, today…

2 months ago
ASSEMBLY APPOINTS KAREN HO AS MANAGING DIRECTOR OF GREATER CHINA TO SPEARHEAD GROWTH IN THE REGIONASSEMBLY APPOINTS KAREN HO AS MANAGING DIRECTOR OF GREATER CHINA TO SPEARHEAD GROWTH IN THE REGION

ASSEMBLY APPOINTS KAREN HO AS MANAGING DIRECTOR OF GREATER CHINA TO SPEARHEAD GROWTH IN THE REGION

Ho will oversee the growth and client development of the agency's business across Mainland China, Hong Kong, and Taiwan. HONG…

3 months ago
Serina Therapeutics Welcomes Karen J. Wilson to its Board of DirectorsSerina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

HUNTSVILLE, AL, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing…

4 months ago